Viemed Healthcare (VMD) Net Cash Flow Growth (3y) (2021 - 2026)
Viemed Healthcare (VMD) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | -48.90% |
| 10 | Viemed Healthcare | 457.68 Mn | 447.92 Mn | 42.83 Mn | -36.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -36.87% |
| Dec 31, 2025 | 36.10% |
| Sep 30, 2025 | -171.57% |
| Jun 30, 2025 | 49.56% |
| Mar 31, 2025 | -120.94% |
| Dec 31, 2024 | 58.99% |
| Sep 30, 2024 | 37.38% |
| Jun 30, 2024 | 202.72% |
| Mar 31, 2024 | -267.60% |
| Dec 31, 2023 | 58.09% |
| Sep 30, 2023 | -27.12% |
| Jun 30, 2023 | -37.95% |
| Mar 31, 2023 | 49.49% |
| Dec 31, 2022 | -102.43% |
| Sep 30, 2022 | -27.85% |
| Jun 30, 2022 | -203.92% |
| Mar 31, 2022 | 31.61% |
| Dec 31, 2021 | 86.12% |
| Sep 30, 2021 | -66.79% |